bf/NASDAQ:RETA_icon.jpeg

NASDAQ:RETA

Reata Pharmaceuticals, Inc.

  • Stock

USD

Last Close

172.32

25/09 20:00

Market Cap

6.57B

Beta: 1.53

Volume Today

1.91M

Avg: 1.45M

PE Ratio

−81.11

PFCF: −26.32

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
asset turnover
0.22
-
0.41
85.38%
0.64
54.08%
0.56
12.20%
0.36
36.54%
0.16
56.28%
0.04
74.97%
0.01
72.94%
0.02
48.64%
0.00
72.45%
cash conversion cycle
-5.60
-
cash per share
32.10
-
15.96
50.29%
7.64
52.13%
4.28
44.02%
5.42
26.82%
12.19
124.87%
21.84
79.13%
24.27
11.12%
16.25
33.04%
10.67
34.35%
company equity multiplier
-0.83
-
-0.46
44.70%
-0.29
36.89%
-0.31
6.52%
-0.92
199.06%
-0.82
10.81%
-0.96
16.95%
-0.89
6.82%
-0.59
34.59%
-7.83
1,237.86%
days of inventory outstanding
days of payables outstanding
5.60
-
days of sales outstanding
77.74
-
107.09
37.75%
231.58
116.25%
899.57
-
dividend yield
0.01
-
ebit per revenue
-0.20
-
0.07
134.41%
-0.01
109.51%
-0.14
1,979.61%
-0.98
607.17%
-1.43
46.96%
-10.76
649.77%
-25.09
133.30%
-21.30
15.13%
-121.91
472.42%
ebt per ebit
1.00
-
1.01
1.54%
0.90
10.64%
0.97
7.16%
1.02
4.87%
1.05
3.08%
1.02
2.87%
1.19
17.37%
1.22
1.93%
1.15
5.13%
effective tax rate
-2.39
-
0.81
133.94%
-3.80
568.05%
0.07
101.74%
-0.00
100.10%
-0.00
413.07%
-0.00
91.46%
0.08
301,910.29%
0.00
98.18%
0.00
94.70%
enterprise value multiple
13.97
-
-2.60
118.65%
20.56
889.43%
-54.24
363.76%
-12.21
77.48%
-16.95
38.76%
-20.08
18.49%
-14.87
25.93%
-2.07
86.09%
-5.42
161.89%
fixed asset turnover
10.33
-
20.65
99.88%
44.06
113.38%
60.87
38.16%
66.93
9.95%
37.09
44.59%
8.85
76.13%
1.84
79.25%
0.08
95.48%
0.02
77.08%
free cash flow per share
-12.59
-
-16.15
28.21%
-8.16
49.45%
-0.99
87.88%
-3.49
253.18%
-3.05
12.71%
-8.35
173.72%
-9.59
14.91%
-6.53
31.95%
-5.71
12.44%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
-3.69
469.13%
1
127.09%
1
0%
1
0%
interest coverage
-32.26
-
-12.45
61.42%
-25.47
104.64%
-6.15
75.84%
-4.60
25.32%
-6.47
40.74%
inventory turnover
long term debt to capitalization
-0.14
-
-0.23
62.43%
-0.28
20.16%
-0.12
-
2.27
1,970.52%
net income per ebt
3.39
-
0.19
94.46%
4.80
2,456.06%
0.93
80.55%
1.00
7.09%
1.00
0.03%
1.00
0.03%
0.92
8.32%
1.00
8.91%
1.00
0.14%
net profit margin
-0.69
-
0.01
101.93%
-0.03
317.29%
-0.12
333.44%
-0.99
694.19%
-1.50
51.52%
-10.94
628.05%
-27.47
151.03%
-25.88
5.78%
-140.75
443.81%
operating cash flow per share
-12.54
-
-16.11
28.55%
-8.11
49.66%
-0.97
88.02%
-3.48
257.94%
-3.02
13.06%
-8.26
173.03%
-9.56
15.80%
-6.49
32.14%
-5.62
13.34%
operating cycle
operating profit margin
-0.20
-
0.07
134.41%
-0.01
109.51%
-0.14
1,979.61%
-0.98
607.17%
-1.43
46.96%
-10.76
649.77%
-25.09
133.30%
-21.30
15.13%
-121.91
472.42%
payables turnover
65.20
-
pretax profit margin
-0.20
-
0.07
134.94%
-0.01
108.50%
-0.13
2,128.45%
-0.99
641.62%
-1.50
51.48%
-10.94
628.26%
-29.96
173.83%
-25.92
13.49%
-140.76
443.03%
price fair value
-0.26
-
-0.26
1.02%
-0.26
0.40%
-1.50
468.10%
-4.61
208.46%
-3.70
19.83%
-8.75
136.69%
-4.35
50.31%
-0.76
82.46%
-21.00
2,653.52%
receivables turnover
4.70
-
3.41
27.41%
1.58
53.76%
0.41
-
return on assets
-0.15
-
0.01
103.59%
-0.02
434.79%
-0.07
280.58%
-0.35
403.97%
-0.23
33.76%
-0.43
82.24%
-0.29
32.06%
-0.40
40.05%
-0.61
49.84%
return on capital employed
-0.09
-
0.05
159.18%
-0.02
134.30%
-0.23
1,168.23%
-0.53
128.95%
-0.27
50.31%
-0.58
118.85%
-0.31
47.30%
-0.36
17.23%
-0.59
65.05%
return on equity
0.13
-
-0.00
101.98%
0.01
311.29%
0.02
305.41%
0.32
1,407.19%
0.19
40.92%
0.41
113.12%
0.26
36.69%
0.24
8.40%
4.75
1,904.59%
total debt to capitalization
-0.27
-
-0.02
93.37%
-0.01
26.82%
-0.02
65.94%
-0.15
609.07%
-0.29
88.67%
-0.86
196.45%
-0.10
88.34%
-0.12
24.11%
2.22
1,882.32%

All numbers in USD (except ratios and percentages)